Fecal microbiota transplantation (FMT), originally endorsed for treating recurrent C. difficile infections, is rapidly diversifying into research on allergies, neurodegenerative diseases, autoimmune disorders, and mental health conditions. Despite unexpected effects such as hair regrowth reported in case studies, scientific interest is intensifying with thousands of studies exploring microbiome modulation's systemic impacts.